Paul McKenzie, Ph.D., is Executive Vice President, Pharmaceutical Operations & Technology of Biogen and has served on the Executive Committee since July 2016. Dr. McKenzie is responsible for asset management, technical development, global manufacturing, supply chain operations, quality, and engineering. He will also oversee construction and operation of Biogen’s advanced biologics manufacturing facility in Solothurn, Switzerland.   He joined the Company in February 2016, as Senior Vice President for Global Biologics Manufacturing & Technical Operations. Prior to joining Biogen, Dr. McKenzie was most recently Vice President of R&D for Johnson & Johnson’s Ethicon business. During his tenure at J&J, Dr. McKenzie led the manufacturing and technical operations team responsible for internal and external manufacturing of Janssen’s pharmaceutical portfolio. He also ran Global Development for Janssen R&D, helping to manage pipeline activities from discovery through clinical development and commercialization. Dr. McKenzie also held various R&D and manufacturing positions at Bristol-Myers Squibb and Merck.   He holds a B.S. in Chemical Engineering from the University of Pennsylvania and a Ph.D. in Chemical Engineering from Carnegie Mellon University. He is a member of the Board of Trustees on the Illinois Institute of Technology and the Society for Biological Engineering and also serves on the Board of Directors of MassBio.

 Chemical Engineering